Generic Drug Pricing and Access in Canada: What are the Implications?
Generic Drug Pricing and Access in Canada: What are the Implications?
June 2010
 
Download the file Download full report
 
Still overpaying for generic drugs
Still overpaying for generic...
Drug Safety and Effectiveness in Canada: Issues, Challenges and New Approaches
Presented at the 2011 CADTH Symposium by John G. Abbott, CEO, Health Council of Canada, with Joel Lexchin (York University), Mary Wiktorowicz (York University), Shilpi Majumder (Health Council of Canada)
  
Cell Padding Image   
This independent paper is designed to move the discussion of possible reforms forward on an important part of the drug file – the pricing and distribution of generic drugs - and to bring transparency to this crucial area of public health policy.
 
 
Supporting Materials
 
Download the file Canadian Generic Pharmaceutical Association responds to Council's 'Generics' discussion paper
Download the file Errata
Download the file Fact Sheet: Generic Drug Pricing Discussion Paper
Download the file Press Release: Health Council of Canada Releases Public Discussion Paper on Generic Drug Prices and Access An Examination of Issues at Play Related
 
Additional Health Council Reports on Pharmaceuticals Management

 

 
HOME                
                 
HEALTH CARE THEMES / PUBLICATIONS   DISCUSSIONS   EVENTS   NEWSROOM   ABOUT
           
Aboriginal Health
Access to Care in the North
Access and Wait Times
Health Human Resources
Health Status and Health Outcomes
Home and Community Care
Pharmaceuticals Management
Primary Health Care
Electronic Health Records
Health Promotion
  Videos
  Podcasts
  Webinars
   
  YouTube
  Facebook
  Twitter

  Calendar
  Challenge
  Symposium
  In the News
  Press Releases
 
Council
Strategic Plan & Bylaw
Collaborations
Careers
Secretariat
 
 
Privacy Policy Cell Padding Image Terms of Use Cell Padding ImageAccessibilityCell Padding ImageDownload Acrobat Reader Copyright © 2005-2013 The Health Council of Canada. All rights reserved.